OBJECTIVES: Oxidative stress plays critical roles in the pathogeneses of diabetes, hypertension, and atherosclerosis, but its effect on fat accumulation is still unclear. In this study, we analyzed the role of the well-known antioxidant and a glutathione (GSH) precursor N-acetylcysteine (NAC) in fat accumulation and the expression of obesity-associated proteins. METHODS: We studied the effects of 10 µM NAC on obesity-related protein expression in cultured 3T3-L1 preadipocytes, which are able to differentiate into mature adipocytes and accumulate lipids. RESULTS: NAC treatment inhibited fat accumulation and reduced the expression of obesity-related proteins, including monoamine oxidase A, heat shock protein 70 (HSP70), aminoacylase -1 (ACY-1), and transketolase. DISCUSSION: Our results suggest that the effects of NAC on triglycerides (Tgs) and protein expression are correlated. In support of this, we showed that NAC treatment affected both the Tg synthesis pathway and the expression levels of proteins implicated in human obesity.
OBJECTIVES: Oxidative stress plays critical roles in the pathogeneses of diabetes, hypertension, and atherosclerosis, but its effect on fat accumulation is still unclear. In this study, we analyzed the role of the well-known antioxidant and a glutathione (GSH) precursor N-acetylcysteine (NAC) in fat accumulation and the expression of obesity-associated proteins. METHODS: We studied the effects of 10 µM NAC on obesity-related protein expression in cultured 3T3-L1 preadipocytes, which are able to differentiate into mature adipocytes and accumulate lipids. RESULTS:NAC treatment inhibited fat accumulation and reduced the expression of obesity-related proteins, including monoamine oxidase A, heat shock protein 70 (HSP70), aminoacylase -1 (ACY-1), and transketolase. DISCUSSION: Our results suggest that the effects of NAC on triglycerides (Tgs) and protein expression are correlated. In support of this, we showed that NAC treatment affected both the Tg synthesis pathway and the expression levels of proteins implicated in humanobesity.
Authors: N Pizzinat; L Marti; A Remaury; F Leger; D Langin; M Lafontan; C Carpéné; A Parini Journal: Biochem Pharmacol Date: 1999-12-01 Impact factor: 5.858
Authors: Ying Lin; Anders H Berg; Puneeth Iyengar; Tony K T Lam; Adria Giacca; Terry P Combs; Michael W Rajala; Xueliang Du; Brent Rollman; Weijie Li; Meredith Hawkins; Nir Barzilai; Christopher J Rhodes; I George Fantus; Michael Brownlee; Philipp E Scherer Journal: J Biol Chem Date: 2004-11-09 Impact factor: 5.157
Authors: James P McClung; Carol A Roneker; Weipeng Mu; Donald J Lisk; Paul Langlais; Feng Liu; Xin Gen Lei Journal: Proc Natl Acad Sci U S A Date: 2004-06-07 Impact factor: 11.205
Authors: Tong Wang; Yaguang Si; Orian S Shirihai; Huiqing Si; Vera Schultz; Richard F Corkey; Liping Hu; Jude T Deeney; Wen Guo; Barbara E Corkey Journal: Obesity (Silver Spring) Date: 2009-12-24 Impact factor: 5.002
Authors: Wen Guo; Yahui Li; Wentao Liang; Siu Wong; Caroline Apovian; James L Kirkland; Barbara E Corkey Journal: PLoS One Date: 2012-07-23 Impact factor: 3.240
Authors: L N Guerra; C Suarez; D Soto; A Schiappacasse; D Sapochnik; P Sacca; G Piwien-Pilipuk; B Peral; J C Calvo Journal: Clin Transl Oncol Date: 2014-12-23 Impact factor: 3.405
Authors: Daniela Soto; María Gomez-Serrano; Azul Pieralisi; Juan C Calvo; Belén Peral; Liliana N Guerra Journal: Redox Rep Date: 2016-09-27 Impact factor: 4.412
Authors: Marco Raffaele; Ignazio Barbagallo; Maria Licari; Giuseppe Carota; Giuseppe Sferrazzo; Mariarita Spampinato; Valeria Sorrenti; Luca Vanella Journal: Evid Based Complement Alternat Med Date: 2018-10-17 Impact factor: 2.629